PET/MR scan for better understanding kidney tumors
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study uses a special PET/MR scanner to take detailed pictures of kidney masses. The goal is to improve diagnosis and help decide the best treatment, without needing a biopsy or prior treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid kidney mass bigger than 2 cm and up to 7 cm in size.
- You are over 18 years old.
- You have not had a biopsy or any treatment for this kidney mass.
- You are not pregnant.
- You have no metal implants or other reasons that would prevent an MRI or PET scan.
- You do not have a genetic condition that causes kidney masses.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether a special PET/CT scan drug ([18F]PT2385) can help doctors see kidney cancer and related tumors. It may help guide diagnosis and treatment decisions, especially in people planning surgery or starting belzutifan.
This study tests whether a special PET scan (using a radioactive tracer called rubidium-82) can help doctors better understand how aggressive a kidney cancer is before surgery. If you have a medium-sized kidney tumor that looks like clear cell cancer and you are scheduled for surgery, you may be able to join.
This study tests a new kind of PET scan that might better detect kidney cancer. It involves an injection of a special imaging agent and a scan to see if the cancer shows up clearly.
This trial tests a new PET/CT scan that uses a special tracer to find clear cell kidney cancer. If you are scheduled for kidney tumor removal, this scan may help your surgeon see the cancer more clearly before surgery.
This trial tests a new imaging agent that might help doctors see whether a kidney mass is cancer before surgery. It may help guide treatment decisions.
This trial studies using a kidney tumor biopsy and a special nuclear scan (SPECT/CT using sestamibi) to help evaluate kidney tumors before surgery. It may help doctors better characterize tumors that appear suspicious on imaging.
Hear when a new Renal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.